These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 33614398)

  • 21. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addressing the global surge of COVID-19 cases: Insights from diagnostics, improved treatment strategies, vaccine development and application.
    Adedokun KA; Olarinmoye AO; Olayemi LO; Shehu MR; Mustapha JO; Kamorudeen RT; Nassar SA
    J Clin Transl Res; 2021 Apr; 7(2):127-139. PubMed ID: 34104816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?
    Noor R
    Curr Clin Microbiol Rep; 2021; 8(3):186-193. PubMed ID: 34249605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advancement in SARS-CoV-2 Diagnosis, Treatment, and Vaccine Formulation: a New Paradigm of Nanotechnology in Strategic Combating of COVID-19 Pandemic.
    Upadhyay SK; Dan S; Girdhar M; Rastogi K
    Curr Pharmacol Rep; 2021; 7(1):1-14. PubMed ID: 33552875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses.
    Amirian ES; Levy JK
    One Health; 2020 Jun; 9():100128. PubMed ID: 32258351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Treatment-Current Status, Advances, and Gap.
    Ho C; Lee PC
    Pathogens; 2022 Oct; 11(10):. PubMed ID: 36297258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current diagnostic and therapeutic strategies for COVID-19.
    Chen B; Liu M; Huang C
    J Pharm Anal; 2021 Apr; 11(2):129-137. PubMed ID: 33520327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered Aptamers for Enhanced COVID-19 Theranostics.
    Acquah C; Jeevanandam J; Tan KX; Danquah MK
    Cell Mol Bioeng; 2021 Jun; 14(3):209-221. PubMed ID: 33488836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development.
    Zhu Y; Li J; Pang Z
    Asian J Pharm Sci; 2021 Jan; 16(1):4-23. PubMed ID: 32837565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.
    Ye C; Qi L; Wang J; Zheng S
    Front Med (Lausanne); 2021; 8():606755. PubMed ID: 33855032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Credible Protein Targets and Curative Strategies for COVID-19: a Review.
    Singh P; Mishra N; Singh N; Nisha R; Pal RR; Singh S; Maurya P; Saraf SA
    SN Compr Clin Med; 2020; 2(11):2067-2076. PubMed ID: 33015546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From Wuhan to COVID-19 Pandemic: An Up-to-Date Review of Its Pathogenesis, Potential Therapeutics, and Recent Advances.
    Zeouk I; Bekhti K; Lorenzo-Morales J
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32512950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine.
    Shaik RA; Ahmad MS; Alzahrani M; Alzerwi NAN; Alnemare AK; Reyzah M; Albar HM; Alshagrawi S; Elkhalifa AME; Alzahrani R; Alrohaimi Y; Mahfoz TMB; Ahmad RK; Alahmdi RA; Al-Baradie NRS
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19.
    Sharma A; Kontodimas K; Bosmann M
    Front Med (Lausanne); 2021; 8():648005. PubMed ID: 34150793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety surveillance and challenges in accelerated COVID-19 vaccine development.
    Cole A; Webster P; Van Liew D; Salas M; Aimer O; Malikova MA
    Ther Adv Drug Saf; 2022; 13():20420986221116452. PubMed ID: 36072284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring status of emergency drugs and vaccine development in Covid-19 pandemic: an update.
    Sharma A; Ahmed S; Kaur J; Chawla R; Rejeeth C
    Virusdisease; 2021 Jun; 32(2):198-210. PubMed ID: 33969152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.